
VolitionRx Limited VNRX
$ 2.95
-5.75%
Quarterly report 2026-Q1
added 05-14-2026
VolitionRx Limited P/S Ratio 2011-2026 | VNRX
Annual P/S Ratio VolitionRx Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.6 | 44.4 | 75 | 291 | 1.74 K | - | 10.8 K | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 10.8 K | 14.6 | 2.16 K |
P/S Ratio of other stocks in the Diagnostics research industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
1.72 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
3.28 | - | - | $ 1.31 B | ||
|
Fulgent Genetics
FLGT
|
1.63 | $ 17.69 | 3.39 % | $ 544 M | ||
|
Guardant Health
GH
|
13.7 | $ 119.49 | 0.45 % | $ 15 B | ||
|
Interpace Biosciences
IDXG
|
0.19 | $ 1.8 | -1.1 % | $ 7.96 M | ||
|
Agilent Technologies
A
|
6.64 | $ 115.43 | 0.44 % | $ 35.1 B | ||
|
Illumina
ILMN
|
3.75 | $ 145.04 | 0.44 % | $ 23.1 B | ||
|
Akumin
AKU
|
0.1 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
9.4 | $ 9.47 | 86.69 % | $ 12.6 M | ||
|
Castle Biosciences
CSTL
|
1.37 | $ 19.68 | -2.36 % | $ 570 M | ||
|
Aspira Women's Health
AWH
|
0.37 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
0.316 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
0.229 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
5.71 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
2.61 | $ 21.37 | -1.2 % | $ 1.14 B | ||
|
Chembio Diagnostics
CEMI
|
0.254 | - | 0.22 % | $ 16.8 M | ||
|
HTG Molecular Diagnostics
HTGM
|
0.469 | - | -20.0 % | $ 1.06 M | ||
|
ICON Public Limited Company
ICLR
|
3.25 | $ 114.69 | -1.79 % | $ 9.46 B | ||
|
Lantheus Holdings
LNTH
|
3.32 | $ 101.26 | -1.69 % | $ 6.83 B | ||
|
Global Cord Blood Corporation
CO
|
0.244 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
3.48 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
19.5 | - | - | $ 7.1 B | ||
|
Mettler-Toledo International
MTD
|
7.06 | $ 1 105.63 | 0.25 % | $ 22.8 B | ||
|
Genetron Holdings Limited
GTH
|
2.9 | - | 0.12 % | $ 80.1 M | ||
|
NeoGenomics
NEO
|
2.04 | $ 9.32 | 1.03 % | $ 1.19 B | ||
|
DermTech
DMTK
|
2.77 | - | -11.32 % | $ 2.94 M | ||
|
National Research Corporation
NRC
|
2.29 | $ 19.06 | -0.1 % | $ 427 M | ||
|
Natera
NTRA
|
6.47 | $ 200.39 | -1.38 % | $ 19.7 B | ||
|
Charles River Laboratories International
CRL
|
1.92 | $ 156.8 | -2.18 % | $ 7.77 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
2.47 | - | - | $ 10.7 B | ||
|
Personalis
PSNL
|
6.19 | $ 9.09 | 7.26 % | $ 811 M | ||
|
Enzo Biochem
ENZ
|
0.0018 | - | -8.98 % | $ 14.8 K | ||
|
Medpace Holdings
MEDP
|
5.12 | $ 430.53 | -0.53 % | $ 12.4 B | ||
|
Exact Sciences Corporation
EXAS
|
6 | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
0.496 | $ 3.87 | 1.18 % | $ 358 M | ||
|
Koninklijke Philips N.V.
PHG
|
1.7 | $ 26.9 | -0.19 % | $ 25.5 B | ||
|
Senseonics Holdings
SENS
|
9.94 | $ 6.39 | 0.79 % | $ 267 M | ||
|
QIAGEN N.V.
QGEN
|
5.03 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
10.9 | - | - | $ 2.69 B | ||
|
Twist Bioscience Corporation
TWST
|
4.15 | $ 64.55 | 6.57 % | $ 3.86 B | ||
|
Biomerica
BMRA
|
1.35 | $ 2.43 | -2.41 % | $ 5.58 M | ||
|
Laboratory Corporation of America Holdings
LH
|
1.71 | $ 259.74 | -0.1 % | $ 21.6 B | ||
|
Thermo Fisher Scientific
TMO
|
4.4 | $ 448.63 | 0.08 % | $ 169 B | ||
|
Trinity Biotech plc
TRIB
|
3.15 | $ 0.66 | 10.27 % | $ 237 M | ||
|
Motus GI Holdings
MOTS
|
3.1 | - | -34.28 % | $ 263 K | ||
|
Waters Corporation
WAT
|
21.1 | $ 340.73 | -0.48 % | $ 20.3 B | ||
|
Neogen Corporation
NEOG
|
1.14 | $ 9.18 | 3.15 % | $ 1.99 B | ||
|
Quest Diagnostics Incorporated
DGX
|
2.11 | $ 193.43 | -0.91 % | $ 21.5 B |